Targeting errant immune system enzyme kills myelodysplastic cells
Scientists have successfully targeted a malfunctioning immune system enzyme to kill diseased cells from patients with myelodysplastic syndrome (MDS)—a blood disorder and precursor to leukemia.
Jul 8, 2013
0
0